The DOI matches its Crossref record.
Neutralizing and Protective Antibodies Directed against Vaccinia Virus Envelope Antigens
Open accessAbstract
The infection mechanism of vaccinia virus is largely unknown. Neither the attachment protein of extracellular enveloped virus (EEV), the biologically relevant infectious form of the virus, nor its cellular receptor has been identified. Surprisingly, all former attempts using antibodies to block EEV infection of cells in vitro had failed. Here, we report the production of an anti-envelope hyperimmune serum with EEV neutralizing activity and show that a polyclonal antiserum against the extraviral domain of protein B5R also inhibited EEV infection. In vivo, mice vaccinated with B5R protein were protected against a lethal vaccinia virus challenge. This protectivity is likely to be mediated by neutralizing antibodies. Protein A33R, but not A34R and A36R, also proved to be protective in active and passive vaccination experiments. However, in contrast to B5R, A33R protectivity did not correlate with antibody titers. Because anti-A33R antibodies did not neutralize EEV in vitro, the protectivity mediated by A33R protein probably involves a mechanism different from simple antibody binding. Taken together, our results suggest that antibodies to a specific protective epitope or epitopes on protein B5R are able to prevent EEV infection. The protein encoded by the B5R gene is therefore likely to play a crucial role in the initial steps of vaccinia virus infection-binding to a host cell and entry into its cytoplasm.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Duration of antiviral immunity after smallpox vaccination
Hammarlund, E., Lewis, M. W., Hansen, S. G., Strelow, L. I., Nelson, J. A., Sexton, G. J., Hanifin, J. M., & Slifka, M. K. (2003) · Nature Medicine · doi:10.1038/nm917 · Cited by 946
The formation and function of extracellular enveloped vaccinia virus
Smith, G. L., Vanderplasschen, A., & Law, M. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-12-2915 · Cited by 559
Review: Capripoxvirus Diseases: Current Status and Opportunities for Control
Tuppurainen, E. S. M., Venter, E. H., Shisler, J. L., Gari, G., Mekonnen, G. A., Juleff, N., Lyons, N. A., De Clercq, K., Upton, C., Bowden, T. R., et al. (2017) · Transboundary and Emerging Diseases · doi:10.1111/tbed.12444 · Cited by 384
Belyakov, I. M., Earl, P., Dzutsev, A., Kuznetsov, V. A., Lemon, M., Wyatt, L. S., Snyder, J. T., Ahlers, J. D., Franchini, G., Moss, B., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1233578100 · Cited by 278
Smallpox vaccines: targets of protective immunity
Moss, B. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00975.x · Cited by 259
Metadata
- Authors
- Galmiche, M. C., Goenaga, J., Wittek, R., & Rindisbacher, L.
- Venue
- Virology
- Publisher
- Elsevier BV
- Published
- 1999-02
- Volume
- 254
- Issue
- 1
- Pages
- 71-80
- ISSN
- 0042-6822 (ISSN-L)
- OpenAlex
- W2072719641
- Cited by
- 218
- References
- 0
- FWCI
- 1.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neutralizing and Protective Antibodies Directed against Vaccinia Virus Envelope Antigens. https://app.cochat.ai/papers/10.1006/viro.1998.9516
- The paper
- Galmiche, M. C., Goenaga, J., Wittek, R., & Rindisbacher, L. (1999). Neutralizing and Protective Antibodies Directed against Vaccinia Virus Envelope Antigens. Virology. https://doi.org/10.1006/viro.1998.9516
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.